Flupentixol Decanoate Dosing
For adults with schizophrenia, initiate flupentixol decanoate at 12.5-25 mg intramuscularly every 2-4 weeks, with an optimal maintenance dose typically between 20-40 mg every 2 weeks. 1
Standard Adult Dosing
Initial Dose:
- Start with 12.5-25 mg (0.5-1 mL) IM to initiate therapy 1
- Onset of action appears between 24-72 hours post-injection
- Significant effects on psychotic symptoms emerge within 48-96 hours 1
Maintenance Dosing:
- Optimal range: 20-40 mg every 2 weeks 2
- A single injection may control symptoms for up to 4 weeks or longer 1
- Some patients on maintenance may respond for up to 6 weeks 1
- Maximum dose should not exceed 100 mg; if doses >50 mg are needed, increase cautiously in 12.5 mg increments 1
The evidence strongly supports 2-week intervals as they provide the highest trough plasma concentration per dose and the lowest peak-to-trough ratio 2. Research demonstrates that the dose-response curve rises steeply between 10 mg every 2 weeks and reaches maximum efficacy (80-95% success rates) between 20-40 mg every 2 weeks 2.
Conversion from Oral Flupentixol
Conversion ratio: Approximately 12.5 mg (0.5 mL) decanoate every 3 weeks for every 10 mg oral flupentixol hydrochloride daily 1
- Example: 20 mg oral daily = 25 mg (1 mL) decanoate every 3 weeks
- After conversion, carefully monitor and adjust dosage at each injection 1
Elderly Patients
Reduce initial doses in elderly or frail patients - specific dose reductions are not explicitly defined in the FDA label, but clinical practice suggests starting at the lower end of the dosing range (12.5 mg) 1. The general principle from related antipsychotic guidelines emphasizes using lower doses in older patients and titrating gradually 3.
Hepatic Impairment
Use with caution but no specific dose adjustment is mandated in the FDA label 1. The evidence does not provide explicit dosing modifications for hepatic impairment with flupentixol decanoate. However, related antipsychotic guidelines recommend dose reduction in patients with hepatic impairment 3.
Practical approach:
- Start at 12.5 mg every 2-4 weeks
- Monitor closely for adverse effects
- Titrate more conservatively than in patients with normal hepatic function
- Consider extending dosing intervals if needed
Important Clinical Considerations
Individual Variability: Plasma concentrations can vary up to 5-fold among individuals receiving the same dose 2. The minimum effective dose shows substantial inter-individual variation (range 20-250 mg every 2 weeks in research studies) 4.
Extrapyramidal Side Effects (EPSEs): EPSEs are frequently observed (12-71% of participants) in the 20-40 mg dose range 2. In first-episode schizophrenia, EPSEs typically peak at month 3 of treatment 5. Keep doses below 40 mg every 2 weeks to minimize these effects while maintaining efficacy.
Poor Risk Patients: For patients with known hypersensitivity to phenothiazines or predisposing disorders, initiate therapy cautiously with oral or short-acting parenteral flupentixol first to establish tolerance and appropriate dosage before switching to the decanoate formulation 1.
Administration: